Maynard Um
-
-
-
-
-
-
-
Elite Pharmaceuticals completes bioequivalence study for anticonvulsant
-
-
-
-
-
-
-
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
-
-
-
-
-
-
-
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
-
-
-
-
-
-
-
Elite Pharmaceuticals (ELTP) Receives FDA Approval for Generic Vyvanse
-
-
-
-
-
-
-
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information
-
-
-
435,852 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

